Sonoma Pharmaceuticals, Inc. (SNOA) › Operating Cash FlowSonoma Pharmaceuticals, Inc. (SNOA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$4.43M2012: -$4.03M2013: $1.15M2019: -$11.72M2020: -$4.59M2021: -$3.38M2022: -$4.25M2023: -$6.15M2024: -$2.40M2025: -$88.0K2026: -$3.93M-$3.93M2011Operating Cash Flow (USD)2026Fiscal YearOperating Cash FlowChange YoY2026-$3.93M-4369.3%2025-$88.0K+96.3%2024-$2.40M+61.0%2023-$6.15M-44.8%2022-$4.25M-25.8%2021-$3.38M+26.4%2020-$4.59M+60.8%2019-$11.72M—2013$1.15M+128.5%2012-$4.03M+9.0%2011-$4.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share